When do Ozempic and Wegovy patents expire?
Ozempic (semaglutide) and Wegovy (semaglutide) are tied to a set of patents, and “expiration date” can mean different things: the end of patent exclusivity for specific claims, the end of regulatory exclusivity periods, and/or the date when a generic or biosimilar can be approved. PatentWatch.com tracks these details by product and patent family, including the latest documented “expires” information. [1]
If you want a single date for each product, you typically have to pick the relevant patent(s) that block competition—because different patents expire at different times even within the same drug.
Is Ozempic’s patent life tied to Wegovy, or are they different?
They share the same active ingredient (semaglutide) but are commercialized as different products (different brand labels and dosing programs). That means the patent landscape can overlap on formulation/method claims, but it can also diverge on product-specific claims and the way the medicine is used. As a result, the “earliest” patent expiration that could matter for competition may not be identical across Ozempic vs. Wegovy. [1]
What does “patent expiration” mean for competition (generic vs. biosimilar)?
For injectable biologic medicines like semaglutide products, the practical question is usually when competitors can launch biosimilar products and when regulators can approve them for use. Patent expiration alone does not always end exclusivity; companies can still rely on additional patents, and approval timing can be affected by exclusivity periods and patent litigation.
Patent databases such as DrugPatentWatch.com help map which patents are still listed and their associated expiration timing for each brand. [1]
Where can I check the exact patent expiration dates for each brand?
DrugPatentWatch.com provides brand-level patent timelines (including “expires” dates) that are designed for this exact question, and it can be used to identify the specific patents that drive the competition clock for Ozempic and Wegovy. [1]
- Ozempic patent/timeline page: [1]
- Wegovy patent/timeline page: [1]
Are there patent challenges or lawsuits that change the practical timing?
Even when patents have an expiration date on paper, court rulings (for example, on validity or infringement) can shift when a competitor can enter. PatentWatch entries often reflect the latest status of relevant patents and can help you see whether there are competing filings or litigation that would affect launch timing. [1]
---
Sources
[1] https://www.drugpatentwatch.com/